-
-
-
-
-
-
-
Oppenheimer Assumes Centessa Pharmaceuticals (CNTA) at Outperform
-
-
-
-
-
-
-
Stephens Starts Centessa Pharmaceuticals (CNTA) at Overweight
-
-
-
-
-
-
-
Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 5c
-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) Appoints Stephen Kanes as Chief Medical Officer
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Centessa Pharmaceuticals (CNTA)
-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) Reports Positive Interim Phase 1 Clinical Data for ORX750
-
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

